Ensign Peak Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36M | Buy |
559,744
+121,611
| +28% | +$1.6M | 0.01% | 551 |
|
|
2025
Q1 | $6.3M | Buy |
438,133
+359,133
| +455% | +$5.16M | 0.01% | 577 |
|
|
2024
Q4 | $1.32M | Hold |
79,000
| – | – | ﹤0.01% | 1148 |
|
|
2024
Q3 | $1.26M | Buy |
+79,000
| New | +$1.26M | ﹤0.01% | 1186 |
|
|
2024
Q2 | – | Sell |
-125,157
| Closed | -$1.41M | – | 1719 |
|
|
2024
Q1 | $1.41M | Hold |
125,157
| – | – | ﹤0.01% | 1098 |
|
|
2023
Q4 | $996K | Hold |
125,157
| – | – | ﹤0.01% | 1383 |
|
|
2023
Q3 | $810K | Hold |
125,157
| – | – | ﹤0.01% | 1355 |
|
|
2023
Q2 | $775K | Hold |
125,157
| – | – | ﹤0.01% | 1451 |
|
|
2023
Q1 | $482K | Sell |
125,157
-123,071
| -50% | -$474K | ﹤0.01% | 1650 |
|
|
2022
Q4 | $770K | Hold |
248,228
| – | – | ﹤0.01% | 1377 |
|
|
2022
Q3 | $998K | Buy |
248,228
+125,157
| +102% | +$503K | ﹤0.01% | 1063 |
|
|
2022
Q2 | $599K | Sell |
123,071
-193,530
| -61% | -$942K | ﹤0.01% | 1370 |
|
|
2022
Q1 | $2.84M | Sell |
316,601
-26,691
| -8% | -$239K | 0.01% | 754 |
|
|
2021
Q4 | $3.87M | Buy |
343,292
+56,888
| +20% | +$641K | 0.01% | 742 |
|
|
2021
Q3 | $4.78M | Sell |
286,404
-63,596
| -18% | -$1.06M | 0.01% | 674 |
|
|
2021
Q2 | $7.77M | Buy |
+350,000
| New | +$7.77M | 0.02% | 496 |
|